Skip to main content
. 2016 Aug 11;11(8):e0161040. doi: 10.1371/journal.pone.0161040

Fig 3. Effect of S4, doxorubicin, or the combination of both, on MDA-MB-231 and FaDu tumor xenograft growth.

Fig 3

Relative tumor volume (mean ± SEM) of MDA-MB-231 (A) and FaDu (C) xenografts treated with vehicle (black), S4 (green), vehicle with doxorubicin (red), or S4 with doxorubicin (blue). Linear fits from relative tumor growth were used to estimate the mean time to reach 5 times start volume (T5XSV) of MDA-MB-231 (B) or 7 times start volume (T7XSV) of FaDu (D) xenografts. ** indicates statistical significance with p<0.01.